Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Update on board meeting
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Themis Medicare has updated BSE about its Board meeting scheduled on 13 February 2026. The Board will, among other things, consider issuing convertible equity warrants to the company's Promoters on a preferential basis. This is an update to an earlier intimation dated 6 February 2026 about the same meeting. The actual issue will require shareholder approval and other regulatory clearances before it can proceed. No financial details on the size of the issue or warrant price have been disclosed in this filing.
Promoters putting fresh money into the company via convertible warrants is generally seen as a confidence signal, but it is also a preferential issue that may dilute existing shareholders if and when the warrants are converted. Investors should watch for the next disclosure with issue size, price, and terms before drawing conclusions.